ArticleAmerican journal of cancer research2025
Integrating shear wave elastography and multiparametric MRI for accurate prostate cancer diagnosis.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop a risk prediction model for prostate cancer (PCa) by integrating Shear Wave Elastography (SWE) with Multiparametric Magnetic Resonance Imaging (mpMRI), thereby improving screening accuracy and specificity while reducing unnecessary invasive procedures.
methodsA total of 479 patients who visited Sun Yat-sen Memorial Hospital between May 2019 and July 2023 were included in this retrospective study, with 162 diagnosed with PCa. The patients were randomly divided into a training set (349 cases) and a validation set (130 cases). The primary measurements consisted of the Young's modulus from SWE, the PI-RADS score from mpMRI, and laboratory indicators such as total PSA (tPSA), free PSA (fPSA), and their densities. A multifactorial prediction model integrating imaging and clinical data was constructed and validated.
resultsThe combined model incorporating SWE and mpMRI exhibited high accuracy and robustness in diagnosing PCa, with area under the curve (AUC) values of 0.92 for the training set and 0.91 for the validation set, significantly outperforming individual indicators (P<0.001). The model achieved a sensitivity of 94.87% and a specificity of 96.12%, indicating superior performance in distinguishing PCa from benign lesions. Receiver operating characteristic (ROC) curve analysis and DeLong's test confirmed that the combined model exhibited the highest diagnostic accuracy, reducing false positives and minimizing unnecessary biopsies.
conclusionsThe multifactorial prediction model integrating both imaging and clinical data provides a more precise and reliable tool for the early diagnosis of PCa, with significant potential for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.